FDA+ channel feed – Endpoints News

FDA+ channel feed

RFK Jr. says his opinions of vaccines are ‘irrelevant.’ Former FDA chief Califf disagrees

Last week

FDA gives AbbVie accelerated approval for antibody-drug conjugate in lung cancer

Last week

GSK awaits Nucala decision after FDA target date passes

3 weeks ago

FDA grants Verastem first approval for rare ovarian cancer treatment

3 weeks ago

FDA will convene vaccine advisors to discuss Covid strain updates

3 weeks ago

FDA's ODAC will review drugs for four different cancers at meeting in May

3 weeks ago

What Vinay Prasad means for CBER, vaccines, drug approvals and more

3 weeks ago

Sarepta’s stock plummets after Prasad appointment, low Elevidys sales

3 weeks ago

Trump, FDA zero in on foreign factories to give domestic sites an edge

3 weeks ago

FDA picks controversial doctor Vinay Prasad as CBER director, in about-face from Marks

3 weeks ago

New opioid data may not be generalizable, FDA adcomm says

3 weeks ago

FDA adcomm will review Capricor's cell therapy for Duchenne muscular dystrophy

3 weeks ago

Even as questions grow over RFK Jr.'s vaccine policy, BioNTech doesn't see ‘near-term’ impact

3 weeks ago

Post-Hoc: The big question for the FDA after Stealth’s PDUFA delay

3 weeks ago

Exclusive: After FDA firings, drug reviewers are asked to volunteer for administrative work

4 weeks ago

White House budget request would cut billions at NIH and CDC, add $500M for MAHA

4 weeks ago

FDA withdraws two final guidances, pulls compliance deadlines for bone allograft makers

4 weeks ago

Missing REMS delays Cytokinetics' heart drug PDUFA, stock drops

4 weeks ago

FDA adcomms slated to review data on long-term opioid use, overdoses

4 weeks ago

RFK Jr. claims placebo-controlled vaccine trials are 'radical departure' from past. Experts disagree

4 weeks ago

FDA approves Satsuma's migraine nasal spray after rejection in 2024

4 weeks ago

Exits continue at FDA, as more staff in drug office follow fired colleagues out the door

4 weeks ago

FDA approves J&J's rare disease drug that's expected to compete with argenx and UCB

4 weeks ago

FDA approves Abeona’s skin disease cell therapy

4 weeks ago

First page Previous page 123 4 5 Next page Last page